Spike in Use of Popular Reflux Drug to Treat Infants Causes Alarm
Linked as:
Summary
Reglan, metoclopramide never approved for use in infants
HOUSTON, May 3 /PRNewswire-USNewswire/ -- Recently, researchers have observed a disturbing trend in neonatal units across the country: doctors prescribing Reglan -- also known by its generic name, metoclopramide -- to treat premature infants. This alarming development has raised serious concerns from many consumer safety advocates, particularly because the drug was never approved for use in infants.See the full content of this document
Extract
Spike in Use of Popular Reflux Drug to Treat Infants Causes Alarm
Reglan (metoclopramide) was approved for short term use - no longer than three months - by the Food &...
See the full content of this document
Sponsored links
